Morning Overview on MSN
Intismeran autogene plus Keytruda dropped melanoma recurrence by close to 50% over five years in a Moderna-Merck-NYU trial unveiled at ASCO
Patients with high-risk melanoma who received a personalized mRNA cancer vaccine alongside Keytruda saw their risk of disease ...
A vaccine and a drug that harness the immune system to attack cancer cells, has cut the risk of skin cancer recurrence and ...
A new mRNA melanoma vaccine from Merck and Moderna showed sustained benefits over five years, cutting the risk of cancer ...
A new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted cancer ...
The authors underscored the potential of adjuvant pelvic IMRT (post-surgery pelvic radiation therapy) to enhance locoregional ...
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...
The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful ...
Personalis, Inc. (Nasdaq: PSNL) today announced clinical data from the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting establishing the clinical importance of ultrasensitive MRD ...
An eight-year Indian clinical trial shows that radiation therapy after bladder removal surgery can significantly reduce ...
A lifestyle program that includes low-glycemic index Mediterranean diet plus daily brisk walking and vitamin D ...
It was this oncologist who had a very different recommendation: Try the Oncotype DX Breast Recurrence Score® test, a ...
Here is how robotic surgeries are paving way for new gen cancer treatment in the country - Read on to know all about it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results